John H. Anneken, Ph.D.
Affiliations: | Pharmaceutical Sciences/Biopharmaceuticals | University of Cincinnati, Cincinnati, OH |
Area:
Neuropharmacology of amphetaminesGoogle:
"John Anneken"Mean distance: 19.18 (cluster 11)
Parents
Sign in to add mentor| Gary Gudelsky | grad student | 2012 | University of Cincinnati | |
| (Glutamate and MDMA Neurobehavioral Toxicity.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Anneken JH, Angoa-Perez M, Sati GC, et al. (2016) Dissecting the influence of two structural substituents on the differential neurotoxic effects of methamphetamine and mephedrone on dopamine nerve endings with the use of 4-methylmethamphetamine and methcathinone. The Journal of Pharmacology and Experimental Therapeutics |
| Anneken JH, Cunningham JI, Collins SA, et al. (2013) MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 58-65 |
| Anneken JH, Gudelsky GA. (2012) MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus. Neuropharmacology. 63: 1022-7 |